Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Testosterone Lawsuit Statute of Limitations Defense Rejected in Bellwether Case May 25, 2017 Austin Kirk Add Your Comments The U.S. District Judge presiding over all federal testosterone drug lawsuits has shut down an attempt by AbbVie to dismiss the first Androgel bellwether trial, which is set to begin on June 5, indicating that the statute of limitations and statute of repose defenses were waived by the drug maker’s decision to wait until the eve of trial to raise the issue. There are currently more than 6,500 Androgel lawsuits, Testim lawsuits, Axiron lawsuits and other claims filed over failure to warn about the potential side effects of testosterone treatments, which have been linked to reports of heart attacks, strokes, blood clots and other serious injuries. Given the similar questions of fact and law raised in the cases, complaints filed throughout the federal court system are consolidated as part of a multidistrict litigation (MDL), which is centralized before U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois for coordinated discovery and a series of early trials designed to gauge how juries may respond to certain evidence and testimony that will be repeated throughout the cases. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Since AbbVie’s Androgel is the most widely used testosterone treatment, Judge Kennelly previously established a bellwether process, in which a group of representative cases have been prepared for early trial dates. The cases are designed to raise claims similar to those presented throughout the litigation, and a lawsuit filed by Jeffrey Konrad was previously selected for the first trial date, set to begin on June 5, 2017. While the outcome of the Konrad trial and other bellwether cases will not be binding on other plaintiffs, representative cases without any unusual or outlying issues were selected to help the parties weigh the relatives strengths and weaknesses of other claims, and facilitate eventual testosterone settlement discussions. Only a few weeks before the Konrad trial is set to begin, AbbVie indicated that it intends to argue at trial that the claim should be barred based on the Tennessee statute of limitations and statute of repose, which require that individuals file their claims within a limited amount of time. The time frame provided in Tennessee is particularly short, providing only one year to bring a claim, raising case-specific questions about when the plaintiff knew or could have discovered he had a cause of action. In a case management order (PDF) issued on May 22, Judge Kennelly rejected this defense, indicating that the Court deems the limitations defense waived since it was not raised earlier. Judge Kennelly pointed out that the Konrad claim was selected as a representative case in August 2016, and that both plaintiffs and defendants proposed it as the first case for trial. While AbbVie did include limitations among a long list of affirmative defenses early in the proceedings, the drug maker did not assert the defense at any time during the extensive summary judgment motions filed before trial. The first mention of the intent to raise this “unique defense” was during a conference earlier this month, on May 11. “The Court appreciates that some allowances are appropriately made and that some leeway is appropriately given in view of the fact that AbbVie is dealing with upwards of 4,000 cases that have been consolidated before the Court for pretrial purposes. But that does not excuse AbbVie’s conduct in this particular case,” Judge Kennelly wrote. “The Court would like to believe that this was due to inattention rather than a plan to wait in ambush, but one way or the other, AbbVie’s boilerplate pleading of these affirmative defenses and its inaction even after it zeroed in on this case as a bellwether candidate and later a bellwether trial case was completely inappropriate and unjustifiable.” Judge Kennelly indicated that he would not have had parties pursue discovery, depositions and all the work that went into prepping the Konrad for a bellwether trial had the issue been brought up earlier. He concluded that to allow the defense now would unfairly prejudice Konrad and would be disruptive to the bellwether process, as Konrad’s case was specifically selected because it was an ideal representative lawsuit reflecting similar claims to those presented in thousands of other cases. The case management order came just days after a joint status report (PDF) on May 22, which addressed the possibility of adding additional cases to the AndroGel bellwether trial schedule. Following the Konrad trial next month, additional Androgel bellwether cases are set for trials are expected to begin on July 5, September 18 and January 8, 2018. Additional bellwether cases involving claims against Auxulium Pharmaceuticals, the makers of Testim, are set to begin in early November 2017 and April 2018. Following bellwether trials in the MDL, if the parties fail to reach settlements or another resolution for the litigation, each individual case may be remanded back to the U.S. District Court where it was originally filed for a separate trial dates in the future. Tags: AbbVie, AndroGel, Heart Attack, Stroke, Testosterone, Testosterone Gel More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 1 Comments Robert August 7, 2019 I suffered a heart attack several years ago after using “TESTIM” but was just recently made aware that “TESTIM” was probably the proximate cause of the heart attack which required installation of a Pacemaker and a Stent. Am I too late to file a claim?? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)